Medtronic PLC
I · Analyse IA
En bref
Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.
Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].
Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.
Score Sentinellis
5.3/10
Moderate concerns
Capitalisation boursière
$100.9B
Chiffre d'affaires (12 mois)
$33.5B
II · Actualités récentes
Ce qui a fait bouger le cours
6 stories · ranked by relevance
- macro2026-05-18
Mental Health Matters at Medtronic. Explore Our Employee Benefits
Yahoo Finance
- macro2026-05-19
Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks
Simply Wall St
- macro2026-05-18
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
Yahoo Finance
- macro2026-05-18
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
Yahoo Finance
- macro2026-05-17
A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years
Yahoo Finance
- macro2026-05-14
Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?
Yahoo Finance
Premium · gratuit avec tout compte
Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]
Risques
5
Opportunités
6
Signaux d'alerte
3
Direction
10
23 autres constats dans le rapport complet — gratuit avec tout compte.
Débloquer l'analyse complète de Medtronic PLC
Créez un compte gratuit pour accéder au rapport complet généré par IA, avec les sources citées dans le texte.
- 5 risques, 6 opportunités et 3 signaux d'alerte — chacun avec sa source
- Plus de 100 indicateurs financiers avec graphiques et comparaisons
- Résumés d'actualités complets avec liens vers les sources
- Équipe dirigeante et rémunération
- Export PDF pour la lecture hors ligne
III · Entreprises similaires
À lire également
Same sector · Healthcare or comparable health
L'ajouter à votre liste ?